cinclus pharma header news

Media

Media

News and press releases

Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information. 

Media gallery

Cinclus Pharma Charlotte

Charlotte Stjerngren

Press and IR

E-mail: Send e-mail

E-mail: Send e-mail

Phone: +46 708 768 787

Latest pressreleases


See allSubscribe

Latest News


Cinclus News Christer Aktiedagen Eng Sthlm

Christer Ahlberg presented at Stora Aktiedagen in Stockholm

Christer Ahlberg participated in Aktiespararnas event Stora Aktiedagen again on November 28th, this time in Stockholm. He presented Cinclus Pharma and the positive topline data released for our phase II eGERD study LEED.

Cinclus News Kjell

Kjell Andersson - CSO and founder with decades in gastroenterology

It all started with a summer job at Astra Zeneca. Today, Kjell is one of Sweden's most experienced drug developers in acid secretion inhibition and has played an important role....

Cinclus News Christer Aktiedagen Eng

Christer Ahlberg presents Cinclus Pharma at Stora Aktiedagen

Christer Ahlberg participated in Aktiespararnas event Stora Aktiedagen in Gothenburg on November 7th. He presented Cinclus Pharma and the positive topline data released for our phase II eGERD study LEED last week.

Cinclus Last Patient

Last Patient Out (LPO) from the Phase II study of linaprazan glurate

On September 1st, we had LPO – Last Patient Out, from the Phase II study of linaprazan glurate. The study includes a total of 228 patients.